Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 229

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five‐year results of a phase I–II study and initial findings of a randomized phase III trial

Polgár, Csaba, Sulyok, Zoltán, Fodor, János, Orosz, Zsolt, Major, Tibor, Takácsi‐Nagy, Zoltán, Mangel, László C., Somogyi, András, Kásler, Miklós, Németh, György · 2002 · Journal of Surgical Oncology

Abstract

Background and Objectives: The objectives of this study were to test the feasibility of sole interstitial high‐dose‐rate brachytherapy (HDR‐BT) after breast‐conserving surgery (BCS) for T1 breast cancer in a phase I–II study, and to present the initial findings of a phase III trial comparing the efficacy of tumor bed radiotherapy (TBRT) alone with conventional whole breast radiotherapy (WBRT). Methods: Forty‐five prospectively selected patients with T1 breast cancer undergoing BCS were enrolled into a phase I–II study of TBRT alone, using interstitial HDR implants. HDR‐BT of 7 × 4.33 Gy (n = 8) and 7 × 5.2 Gy (n = 37) was delivered to the tumor bed. Based on the results of this phase I–II study, a further 126 patients were randomized to receive 50 Gy WBRT (n = 63) or TBRT alone (n = 63); the latter consisted of either 7 × 5.2 Gy HDR‐BT (n = 46) or 50‐Gy wide‐field electron irradiation (n = 17). Breast cancer related events and side effects were assessed. Results: In the phase I–II study, at a median follow‐up of 57 months, 2 (4.4%) local, 3 (6.7%) axillary, and 3 (6.7%) distant failures were observed. Two patients (4.4%) died of breast cancer. The 5‐year probability of cancer‐specific, relapse‐free and local recurrence‐free survival was 90.0%, 85.9%, and 95.6%, respectively. The cosmetic results were judged to be excellent in 44 of 45 patients (97.8%). Severe (higher than grade 2) skin sequelae or fibrosis was not found. Symptomatic fat necrosis occurred in one patient (2.2%). In the phase III study, at a median follow‐up of 30 months, the locoregional tumor control was 100% in both arms. The 3‐year probability of cancer‐specific and relapse‐free survival was 98.1% and 98.4% in the WBRT group and 100% and 94.4% in the TBRT group, respectively (P = NS). There was no significant difference between the two treatment arms regarding the incidence of radiation side effects. Conclusions: Five‐year results of our phase I–II study prove that sole HDR‐BT of the tumor bed with careful patient selection and adequate quality assurance is a feasible alternative to WBRT. However, long‐term results of phase III trials are required to determine the equivalence of TBRT alone, compared with WBRT in the management of selected patients with early breast cancer. J. Surg. Oncol. 2002;80:121–128. © 2002 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jso.10110

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 229

Metadata

Authors
Polgár, C., Sulyok, Z., Fodor, J., Orosz, Z., Major, T., Takácsi‐Nagy, Z., Mangel, L. C., Somogyi, A., Kásler, M., & Németh, G.
Venue
Journal of Surgical Oncology
Publisher
Wiley
Published
2002-06-20
Volume
80
Issue
3
Pages
121-128
ISSN
  • 0022-4790 (ISSN-L)
  • 1096-9098
OpenAlex
W1993977806
Cited by
229
References
1
FWCI
9.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.